The Valley Desk

NCT02392676 · Interventional trial

Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

Overall registry status Withdrawn

Phase 3

Conditions Platinum Sensitive Relapsed Ovarian Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov